Biocept Inc (BIOC)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Biocept Inc (BIOC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011918
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Biocept Inc (Biocept) is a developer of diagnostic solutions. The company provides biopharmaceutical and clinical research, and molecular oncology laboratory services. It provides tests for various solid tumor cancers. Biocept offers related instrumentation, OncoCEE technology, and analytical capabilities for rare event detection and genetic characterization. The company’s OncoCEE platform modifies rare cell capture and analyses methods. It offers patented methodology to isolate rare cells including circulating tumor cells, and cell-free circulating tumor DNA from the blood. The company also develops methodology to isolate cancer material including circulating tumor cells, and cell-free circulating tumor DNA. It serves medical and surgical oncologists, pathologists, hospitals, cancer centers, universities, and pharmaceutical and clinical researchers. Biocept is headquartered in San Diego, California, the US.

Biocept Inc (BIOC) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Biocept Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Biocept Inc, Medical Devices Deals, 2011 to YTD 2017 9
Biocept Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Biocept Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Biocept Raises Funds In Growth Equity Financing Round 11
Partnerships 12
Biocept Enters into Research Agreement with University of Minnesota 12
Biocept Enters into Research Agreement with Sarah Cannon Research Institute 13
Biocept Enters into Partnership with Dana-Farber Cancer Institute 14
Equity Offering 15
Biocept Prices Public Offering of Shares for USD3.3 Million 15
Biocept Prices USD3.3 Million in Public Offering of Shares 17
Biocept Plans to Raise Funds through Private Placement of Shares 18
Biocept to Raise USD2.2 Million in Private Placement of Shares and Warrants 19
Biocept Prices Private Placement of Shares and Warrants for USD9.3 Million 20
Biocept Raises USD10 Million in Public Offering of Shares and Warrants 21
Biocept to Raise USD15 Million in Public Offering of Shares 22
Biocept Raises USD10 Million in Public Offering of Shares and Warrants 23
Biocept Completes IPO For US$19 Million 25
Biocept Inc – Key Competitors 26
Biocept Inc – Key Employees 27
Biocept Inc – Locations And Subsidiaries 28
Head Office 28
Recent Developments 29
Financial Announcements 29
Nov 09, 2017: Biocept Reports Third Quarter 2017 Financial Results 29
Aug 10, 2017: Biocept Reports Second Quarter 2017 Financial Results 32
May 11, 2017: Biocept Reports First Quarter 2017 Financial Results 35
Mar 07, 2017: Biocept Reports Fourth Quarter and Full Year 2016 Financial Results 37
Nov 09, 2016: Biocept Reports 2016 Third Quarter Financial Results 39
Aug 02, 2016: Biocept Reports 2016 Second Quarter Financial Results 41
May 12, 2016: Biocept Reports 2016 First Quarter Financial Results 43
Mar 09, 2016: Biocept Reports 2015 Fourth Quarter and Full Year Financial Results 44
Corporate Communications 46
Oct 11, 2017: Renowned Lung Cancer Expert Fred R. Hirsch, M.D., Ph.D. Joins Biocept’s Clinical Advisory Board 46
Jul 27, 2016: Biocept Appoints Timothy C. Kennedy as Chief Financial Officer and Senior Vice President of Operations 47
Mar 23, 2016: Biocept’s Mark Foletta Honored with CFO Lifetime Achievement Award 48
Other Significant Developments 49
Mar 10, 2016: Progenetics to Distribute Biocept’s Liquid Biopsy Assays in Israel 49
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50

List of Tables
Biocept Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Biocept Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Biocept Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Biocept Inc, Medical Devices Deals, 2011 to YTD 2017 9
Biocept Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Biocept Raises Funds In Growth Equity Financing Round 11
Biocept Enters into Research Agreement with University of Minnesota 12
Biocept Enters into Research Agreement with Sarah Cannon Research Institute 13
Biocept Enters into Partnership with Dana-Farber Cancer Institute 14
Biocept Prices Public Offering of Shares for USD3.3 Million 15
Biocept Prices USD3.3 Million in Public Offering of Shares 17
Biocept Plans to Raise Funds through Private Placement of Shares 18
Biocept to Raise USD2.2 Million in Private Placement of Shares and Warrants 19
Biocept Prices Private Placement of Shares and Warrants for USD9.3 Million 20
Biocept Raises USD10 Million in Public Offering of Shares and Warrants 21
Biocept to Raise USD15 Million in Public Offering of Shares 22
Biocept Raises USD10 Million in Public Offering of Shares and Warrants 23
Biocept Completes IPO For US$19 Million 25
Biocept Inc, Key Competitors 26
Biocept Inc, Key Employees 27

★海外企業調査レポート[Biocept Inc (BIOC)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Exco Resources Inc (XCOOQ):石油・ガス:M&Aディール及び事業提携情報
    Summary Exco Resources Inc (Exco Resources) is an oil and gas company that offers crude oil and natural gas. The company offers acquisition, exploration, development, exploitation, operations, management, and production of onshore natural gas and oil assets. It provides services such as portfolio re …
  • PT Jasa Marga (Persero) Tbk:企業の戦略・SWOT・財務情報
    PT Jasa Marga (Persero) Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Jasa Marga (Persero) Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • MedEquities Realty Trust, Inc. (MRT):企業の財務・戦略的SWOT分析
    MedEquities Realty Trust, Inc. (MRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Votorantim SA:企業の戦略的SWOT分析
    Votorantim SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Cortec GmbH:製品パイプライン分析
    Summary Cortec GmbH (Cortec), a subsidiary of Iron Force Industrial Co Ltd is a medical device company that develops neurons technology platform for the measurement and stimulation of brain activity. The company provides products for clinical use and scientific research. It is developing implants th …
  • Optivia Biotechnology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Optivia Biotechnology Inc (Optivia Biotechnology), a subsidiary of BioIVT, is a contract research organization that offers drug transporter research services and solutions. The organization offers products such as single transporter assay plates, multi-transporter model plates and verified e …
  • Dais Analytic Corps (DLYT):企業の財務・戦略的SWOT分析
    Summary Dais Analytic Corps (Dais) is an alternative energy company that provides industry changing and nano technology based applications. The company's products include ultra capacitors, clean water systems, heating and cooling equipment, among others. It also provides NanoAir, NanoCap, ConsERV an …
  • Daelim Industrial Co Ltd:企業の戦略・SWOT・財務情報
    Daelim Industrial Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Daelim Industrial Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Carlisle Companies Incorporated:戦略・SWOT・企業財務分析
    Carlisle Companies Incorporated - Strategy, SWOT and Corporate Finance Report Summary Carlisle Companies Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Allergan plc:企業の戦略・SWOT・財務情報
    Allergan plc - Strategy, SWOT and Corporate Finance Report Summary Allergan plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Celon Pharma SA (CLN)-製薬・医療分野:企業M&A・提携分析
    Summary Celon Pharma SA (Celon Pharma) is an integrated pharmaceutical company which carries out research and develops novel therapies. Its product portfolio includes Aromek, Salmex, Valzek, Lazivir, Bosentan Celon, Donepex and Ketrel. The company primarily focuses on the development of pharmaceutic …
  • Enea AB (ENEA):企業の財務・戦略的SWOT分析
    Summary Enea AB (Enea) is a technology company that provides software solutions. The company offers embedded technologies, testing and validation, certifications, software outsourcing, research and development centers, professional staffing and packaged services. It offers realtime operating system …
  • Norwest Venture Partners XII, LP:企業のM&A・事業提携・投資動向
    Norwest Venture Partners XII, LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Norwest Venture Partners XII, LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Sembcorp Industries Ltd (U96):電力:M&Aディール及び事業提携情報
    Summary Sembcorp Industries Ltd (Sembcorp) is a diversified energy, water and marine company. It provides solutions across the energy and utilities value chain, with a focus on gas and power, renewables and environment, and merchant and retail sectors. The company carries out production and supply o …
  • Mylan N.V.:戦略・SWOT・企業財務分析
    Mylan N.V. - Strategy, SWOT and Corporate Finance Report Summary Mylan N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Support.com, Inc. (SPRT):企業の財務・戦略的SWOT分析
    Support.com, Inc. (SPRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Energias de Portugal SA (EDP):石油・ガス:M&Aディール及び事業提携情報
    Summary Energias de Portugal, S.A. (EDP) is a vertically integrated power and gas utility that generates, transmits, distributes and sells electricity; and transports, distributes and sells natural gas. It produces electricity through a diversified portfolio of generation assets including wind, sola …
  • Aluminum Corporation of China Ltd:企業の戦略・SWOT・財務情報
    Aluminum Corporation of China Ltd - Strategy, SWOT and Corporate Finance Report Summary Aluminum Corporation of China Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Kolltan Pharmaceuticals, Inc.:企業のM&A・事業提携・投資動向
    Kolltan Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kolltan Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Telekom Malaysia Berhad (TM):企業の財務・戦略的SWOT分析
    Telekom Malaysia Berhad (TM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆